Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma

被引：12
作者：
Song, Hao [1 ]
Wang, Lizhen [2 ]
Lyu, Jiong [3 ]
Wu, Yunteng [1 ]
Guo, Wei [1 ]
Ren, Guoxin [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai 200011, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Oral Pathol, Shanghai 200011, Peoples R China
[3] Zhejiang Univ, Dept Stomatol, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
来源：
ONCOTARGET | 2017年 / 8卷 / 17期
关键词：
oral mucosa; melanoma; BAP1; prognosis; immunohistochemistry; PRIMARY MALIGNANT-MELANOMA; OF-THE-LITERATURE; UVEAL MELANOMA; UBIQUITIN HYDROLASE; NECK DISSECTION; MUTATIONS; TUMORS; HEAD; IMMUNOHISTOCHEMISTRY; INHIBITORS;
D O I：
10.18632/oncotarget.16175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Oral mucosal melanoma (OMM) is an aggressive neoplasm with an extremely poor prognosis. BAP1 is a tumor suppressor that has been associated with the outcome of melanomas and other malignancies. In this study, we investigated the genetic alterations in BAP1 and the prognostic potential of BAP1 protein expression in oral mucosal melanoma. DNA sequence analysis of BAP1 from 12 OMM patient samples revealed missense mutations in the tissues from four patients. Based on immunohistochemical staining, loss of nuclear BAP1 expression was associated with poor overall survival (P < 0.001, Log-rank = 21.308) and distant metastasis (P = 0.034, OR = 0.320). Multivariate analysis showed BAP1 to be an independent prognostic factor (P = 0.027, HR = 0.479). It thus appears that loss of nuclear BAP1 expression is an independent prognostic factor of poor overall survival and associated with distant metastasis in OMM.
引用
收藏
页码：29080 / 29090
页数：11
相关论文
共 50 条
  • [31] Tumours associated with BAP1 mutations
    Murali, Rajmohan
    Wiesner, Thomas
    Scolyer, Richard A.
    PATHOLOGY, 2013, 45 (02) : 116 - 126
  • [32] Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations
    Yavuzyigitoglu, Serdar
    Mensink, Hanneke W.
    Smit, Kyra N.
    Vaarwater, Jolanda
    Verdijk, Robert M.
    Beverloo, Berna
    Bruggenwirth, Hennie T.
    van Marion, Ronald
    Dubbink, Hendrikus J.
    Paridaens, Dion
    Naus, Nicole C.
    de Klein, Annelies
    Kilic, Emine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (04) : 2232 - 2239
  • [33] Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma
    da Costa, Walter Henriques
    Fares, Aline Fusco
    Bezerra, Stephania M.
    Morini, Mariana A.
    de Toledo Benigno, Ligia Alencar
    Clavijo, Diego Abreu
    Fornazieri, Lucas
    Rocha, Mauricio Murce
    da Cunha, Isabela Werneck
    Zequi, Stenio de Cassio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (01) : 78 - 85
  • [34] Loss of BAP1 expression is a very rare event in gastrointestinal stromal tumors
    Kwon, Hee Jung
    Choi, Joon Hyuk
    Gu, Mi Jin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (09): : 13710 - 13715
  • [35] Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations
    Gupta, Mrinali P.
    Lane, Anne Marie
    DeAngelis, Margaret M.
    Mayne, Katie
    Crabtree, Margaux
    Gragoudas, Evangelos S.
    Kim, Ivana K.
    JAMA OPHTHALMOLOGY, 2015, 133 (08) : 881 - 887
  • [36] BAP1 Has a Survival Role in Cutaneous Melanoma
    Kumar, Raj
    Taylor, Michael
    Miao, Benchun
    Ji, Zhenyu
    Njauw, Jenny C-N
    Jonsson, Goran
    Frederick, Dennie T.
    Tsao, Hensin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (04) : 1089 - 1097
  • [37] Prognostic and Clinicopathological Significance of BAP1 Protein Expression in Different Types of CancerA Meta-Analysis
    Wang, Zheng
    Wang, Xiang-Yu
    Li, Juan
    Zhu, Wen-Wei
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (02) : 115 - 126
  • [38] Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma
    Joseph, Richard W.
    Kapur, Payal
    Serie, Daniel J.
    Eckel-Passow, Jeanette E.
    Parasramka, Mansi
    Ho, Thai
    Cheville, John C.
    Frenkel, Eugene
    Rakheja, Dinesh
    Brugarolas, James
    Parker, Alexander
    CANCER, 2014, 120 (07) : 1059 - 1067
  • [39] Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma
    Kim, Min Jong
    Gu, Mi Jin
    Chang, Hee-Kyung
    Yu, Eunsil
    HISTOPATHOLOGY, 2015, 66 (04) : 508 - 516
  • [40] Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma
    Sim, Jongmin
    Kim, Yeseul
    Kim, Hyungsung
    Bang, Seongsik
    Jee, Seungyun
    Park, Seongun
    Shin, Su-Jin
    Jang, Kiseok
    IN VIVO, 2020, 34 (01): : 125 - 132
12345